Full Press Release Details
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
CLEVELAND, OH, November 20, 2024 - Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, will hold an Investor Day in New York City where Sotera Health s
management team will discuss the Company s strategic positioning and outline future growth plans. Management will take questions from a live audience during two
question-and-answer sessions.
The management team is looking
forward to the Company s inaugural Investor Day since going public in 2020, said Michael J. Petras, Jr., Chair and CEO. During the past four years, we have achieved top- and bottom-line growth
with strong margins, generated significant operating cash flow, demonstrated disciplined capital deployment, and maintained durable customer relationships. I m proud of what we ve accomplished and look forward to the team sharing more
about future growth drivers at today s investor event.
During today s presentation, management will:
The Company does not provide a reconciliation for non-GAAP financial measures on a forward-looking basis where it is
unable to provide a meaningful or accurate calculation or estimation of reconciling items without unreasonable effort. The Company cannot reconcile its expected Adjusted EBITDA, Adjusted EBITDA margins, Adjusted EBITDA growth rate and Free Cash Flow
without unreasonable effort because certain items that impact net income, earnings per share and other reconciling metrics are out of the Company s control and/or cannot be reasonably predicted at this time, including uncertainties caused by
changes to the regulatory landscape, restructuring items and certain fair value measurements, all of which are potential adjustments for future earnings.
9100 South Hills Boulevard, Suite 300,
Broadview Heights, OH 44147
440-262-1410 | soterahealth.com
A live webcast of the event will be accessible at Presentation & Events | Sotera Health. Virtual participants are encouraged to pre-register at this link and log in to the webcast approximately 5-10 minutes prior to the start of the event. A live question-and-answer session will follow management s prepared remarks. Sotera Health intends to make the investor presentation for the event available concurrently with the start of the event. A replay
of the video webcast will be available within 48 hours following the conclusion of the event at Presentation & Events | Sotera Health. Presentation slides and a webcast replay will be available on the Investor Relations page for 12
Sotera Health Company
is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes
to market through three businesses Sterigenics , Nordion and Nelson
Labs . Sotera Health is committed to its mission, Safeguarding Global Health .
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company s website
at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACT
Vice President Investor Relations & Treasurer
Chief Marketing Officer
Source: Sotera Health Company
9100 South Hills Boulevard, Suite 300,
Broadview Heights, OH 44147
440-262-1410 | soterahealth.com